Skip to main content
. 2024 Jan 24;12(2):260. doi: 10.3390/biomedicines12020260

Table 3.

Primary and secondary outcomes of patients according to their neutrophil/lymphocyte ratio levels *.

Variables Quartile #1 (n = 1010) Quartile #2 (n = 1010) Quartile #3 (n = 1009) Quartile #4 (n = 1010) Univariable Analysis Multivariable Analysis **
p Value Odds Ratio (95% CI) p Value
Hospital mortality, no. (%) 24 (2.4) 27 (2.7) 34 (3.4) 43 (4.3) 0.075 Q#2 1.09 (0.62, 1.93) 0.763
Q#3 1.3 (0.76, 2.23) 0.343
Q#4 1.28 (0.76, 2.16) 0.352
Mortality at 6 months, no. (%) 162 (16) 144 (14.3) 152 (15.1) 180 (17.8) 0.147 Q#2 0.83 (0.64, 1.07) 0.149
Q#3 0.84 (0.66, 1.08) 0.185
Q#4 0.86 (0.68, 1.1) 0.238
Need for invasive mechanical ventilation, no. (%) 152 (15) 165 (16.3) 185 (18.3) 202 (20) 0.018 Q#2 1.07 (0.84, 1.37) 0.581
Q#3 1.19 (0.93, 1.51) 0.164
Q#4 1.12 (0.88, 1.43) 0.341
Need for invasive and non-invasive mechanical ventilation, no. (%) 300 (29.7) 324 (32.1) 346 (34.3) 378 (37.4) 0.002 Q#2 1.08 (0.89, 1.32) 0.422
Q#3 1.15 (0.95, 1.4) 0.158
Q#4 1.12 (0.92, 1.37) 0.254
ICU admission 319 (31.6) 363 (35.9) 405 (40.1) 492 (48.7) <0.001 Q#2 1.19 (0.97, 1.46) 0.090
Q#3 1.38 (1.13, 1.69) 0.002
Q#4 1.64 (1.34, 2.01) <0.001
p value Estimate (95% CI) p value
Hospital-free days, median (IQR) 24.3 (22.06, 25.88) 24.01 (21.12, 25.48) 23.98 (21, 25.41) 23.55 (19.96, 25.23) <0.001 Q#2 −0.41 (−0.93, 0.11) 0.120
Q#3 −0.43 (−0.95, 0.09) 0.104
Q#4 −0.63 (−1.15, −0.11) 0.017

CI: confidence interval, ICU: intensive care unit, IQR: interquartile range, Q: quartile. * Neutrophil-lymphocyte ratio levels per quartiles: Quartile #1, <5.13; Quartile #2, ≥5.13 and <9.26; Quartile #3, ≥9.26 and <16.35; Quartile #4, ≥16.35. ** Data were analyzed using multivariable regression models adjusting for pneumonia severity index. Quartile #1 was the reference.